Walleye Trading LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 231 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.

Quarter-by-quarter ownership
Walleye Trading LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$931,507
+343.5%
24,385
+343.4%
0.00%
Q1 2023$210,045
-95.9%
5,500
-93.9%
0.00%
-100.0%
Q4 2022$5,169,081
+899.8%
90,845
+593.5%
0.02%
+1400.0%
Q3 2022$517,000
-16.6%
13,100
-7.1%
0.00%0.0%
Q2 2022$620,000
-7.5%
14,099
-16.0%
0.00%0.0%
Q1 2022$670,000
-10.9%
16,785
-10.2%
0.00%
-66.7%
Q4 2021$752,000
-70.9%
18,700
-70.5%
0.00%
-66.7%
Q3 2021$2,580,000
+80.0%
63,400
+84.5%
0.01%
+50.0%
Q1 2021$1,433,000
-25.9%
34,371
-24.1%
0.01%
-33.3%
Q4 2020$1,935,000
-4.2%
45,300
-41.0%
0.01%
-18.2%
Q3 2020$2,019,000
-21.0%
76,800
-19.4%
0.01%
-31.2%
Q2 2020$2,555,000
+127.3%
95,300
+52.5%
0.02%
+77.8%
Q1 2020$1,124,000
+33.2%
62,500
+31.3%
0.01%
+50.0%
Q4 2019$844,000
+10.9%
47,600
-3.0%
0.01%0.0%
Q3 2019$761,000
+50.7%
49,053
+66.9%
0.01%
+20.0%
Q2 2019$505,00029,385
+122337.5%
0.01%
Q3 2018$0
-100.0%
24
-99.9%
0.00%
-100.0%
Q2 2018$290,000
-23.1%
17,200
-20.7%
0.00%
-50.0%
Q3 2017$377,000
+37600.0%
21,700
+21600.0%
0.00%
Q2 2017$1,000
-98.2%
100
-98.3%
0.00%
Q1 2016$55,000
+292.9%
5,800
+642.6%
0.00%
Q4 2015$14,000
+27.3%
781
+56.2%
0.00%
Q2 2015$11,0005000.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
TRAN CAPITAL MANAGEMENT, L.P. 1,506,473$61,283,0005.13%
First Light Asset Management, LLC 1,477,496$60,105,0003.96%
SNYDER CAPITAL MANAGEMENT L P 3,427,476$139,430,0003.69%
DOHENY ASSET MANAGEMENT /CA 80,400$3,271,0002.34%
Redwood Investments, LLC 619,766$25,212,0002.11%
HighMark Wealth Management LLC 53,341$2,170,0001.60%
SILVERARC CAPITAL MANAGEMENT, LLC 60,170$2,448,0001.38%
Third Security, LLC 168,604$6,859,0001.33%
Taylor Wealth Management Partners 87,654$3,566,0001.27%
Penn Capital Management Company, LLC 290,394$11,813,0001.19%
View complete list of HALOZYME THERAPEUTICS INC shareholders